These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Polymorphisms in the K13-Propeller Gene in Artemisinin-Resistant Zheng S; Liang Y; Wang Z; Liu M; Chen Y; Ai Y; Guo W; Li G; Yuan Y; Xu Z; Wu W; Huang X; Wu Z; Xu Q; Song J; Deng C Infect Drug Resist; 2022; 15():6533-6544. PubMed ID: 36386414 [TBL] [Abstract][Full Text] [Related]
4. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity. Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510 [TBL] [Abstract][Full Text] [Related]
5. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam. Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808 [TBL] [Abstract][Full Text] [Related]
6. Persistence of chloroquine-resistant haplotypes of Plasmodium falciparum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine. Oladipo OO; Wellington OA; Sutherland CJ Diagn Pathol; 2015 Apr; 10():41. PubMed ID: 25928117 [TBL] [Abstract][Full Text] [Related]
7. Antiplasmodial profile of selected compounds from Malaria Box: in vitro evaluation, speed of action and drug combination studies. de Souza GE; Bueno RV; de Souza JO; Zanini CL; Cruz FC; Oliva G; Guido RVC; Aguiar ACC Malar J; 2019 Dec; 18(1):447. PubMed ID: 31888654 [TBL] [Abstract][Full Text] [Related]
8. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo. Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564 [TBL] [Abstract][Full Text] [Related]
9. Molecular detection of drug resistant malaria in Southern Thailand. Noisang C; Prosser C; Meyer W; Chemoh W; Ellis J; Sawangjaroen N; Lee R Malar J; 2019 Aug; 18(1):275. PubMed ID: 31416468 [TBL] [Abstract][Full Text] [Related]
10. K13-propeller gene polymorphisms in Plasmodium falciparum parasite population in malaria affected countries: a systematic review of prevalence and risk factors. Ocan M; Akena D; Nsobya S; Kamya MR; Senono R; Kinengyere AA; Obuku E Malar J; 2019 Mar; 18(1):60. PubMed ID: 30846002 [TBL] [Abstract][Full Text] [Related]
11. Limited artemisinin resistance-associated polymorphisms in Plasmodium falciparum K13-propeller and PfATPase6 gene isolated from Bioko Island, Equatorial Guinea. Li J; Chen J; Xie D; Eyi UM; Matesa RA; Ondo Obono MM; Ehapo CS; Yang L; Yang H; Lin M Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):54-59. PubMed ID: 27054064 [TBL] [Abstract][Full Text] [Related]
12. Endoperoxide-based compounds: cross-resistance with artemisinins and selection of a Plasmodium falciparum lineage with a K13 non-synonymous polymorphism. Paloque L; Witkowski B; Lelièvre J; Ouji M; Ben Haddou T; Ariey F; Robert A; Augereau JM; Ménard D; Meunier B; Benoit-Vical F J Antimicrob Chemother; 2018 Feb; 73(2):395-403. PubMed ID: 29177421 [TBL] [Abstract][Full Text] [Related]
13. Correlation of Sharma S; Bharti RS; Bhardwaj N; Anvikar AR; Valecha N; Mishra N Indian J Med Microbiol; 2017; 35(4):485-490. PubMed ID: 29405138 [TBL] [Abstract][Full Text] [Related]
14. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season. Alareqi LMQ; Mahdy MAK; Lau YL; Fong MY; Abdul-Ghani R; Mahmud R Acta Trop; 2016 Oct; 162():174-179. PubMed ID: 27343362 [TBL] [Abstract][Full Text] [Related]
15. A Redox-Active Fluorescent pH Indicator for Detecting Plasmodium falciparum Strains with Reduced Responsiveness to Quinoline Antimalarial Drugs. Jida M; Sanchez CP; Urgin K; Ehrhardt K; Mounien S; Geyer A; Elhabiri M; Lanzer M; Davioud-Charvet E ACS Infect Dis; 2017 Feb; 3(2):119-131. PubMed ID: 28183182 [TBL] [Abstract][Full Text] [Related]
16. Status of Artemisinin Resistance in Malaria Parasite Oboh MA; Ndiaye D; Antony HA; Badiane AS; Singh US; Ali NA; Bharti PK; Das A Biomed Res Int; 2018; 2018():2305062. PubMed ID: 30402465 [TBL] [Abstract][Full Text] [Related]
17. Analysis of genetic diversity in the chloroquine-resistant gene Pfcrt in field Plasmodium falciparum isolates from five regions of the southern Cameroon. Ngassa Mbenda HG; Das A Infect Genet Evol; 2016 Oct; 44():450-458. PubMed ID: 27389361 [TBL] [Abstract][Full Text] [Related]
18. The chemotherapy of rodent malaria. LVIII. Drug combinations to impede the selection of drug resistance, Part. 2: The new generation--artemisinin or artesunate with long-acting blood schizontocides. Peters W; Robinson BL Ann Trop Med Parasitol; 2000 Jan; 94(1):23-35. PubMed ID: 10723521 [TBL] [Abstract][Full Text] [Related]
20. Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014. Mishra S; Bharti PK; Shukla MM; Ali NA; Kashyotia SS; Kumar A; Dhariwal AC; Singh N Pathog Glob Health; 2017 Jun; 111(4):186-194. PubMed ID: 28549390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]